scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.ADDR.2016.01.018 |
P698 | PubMed publication ID | 26836397 |
P2093 | author name string | Paul D Leeson | |
P2860 | cites work | Molecular complexity and its impact on the probability of finding leads for drug discovery | Q30993107 |
Is there a difference between leads and drugs? A historical perspective | Q31017131 | ||
Chemical predictive modelling to improve compound quality | Q38167262 | ||
Comparing Measures of Promiscuity and Exploring Their Relationship to Toxicity | Q51434929 | ||
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 22-33 | |
P577 | publication date | 2016-01-30 | |
P13046 | publication type of scholarly work | review article | Q7318358 |
P1433 | published in | Advanced Drug Delivery Reviews | Q2825362 |
P1476 | title | Molecular inflation, attrition and the rule of five | |
P478 | volume | 101 |
Q61813071 | Application of Permeation Enhancers in Oral Delivery of Macromolecules: An Update |
Q47780833 | Automating drug discovery |
Q38835159 | BDDCS, the Rule of 5 and drugability |
Q47895991 | CNS Physicochemical Property Space Shaped by a Diverse Set of Molecules with Experimentally Determined Exposure in the Mouse Brain. |
Q90476028 | Chemical Space Overlap with Critical Protein-Protein Interface Residues in Commercial and Specialized Small-Molecule Libraries |
Q55364364 | Clinical Trials for Disease-Modifying Therapies in Alzheimer's Disease: A Primer, Lessons Learned, and a Blueprint for the Future. |
Q38732067 | Computational analysis of calculated physicochemical and ADMET properties of protein-protein interaction inhibitors |
Q26765392 | Computational prediction of formulation strategies for beyond-rule-of-5 compounds |
Q36342657 | Enhancing Drug Efficacy and Therapeutic Index through Cheminformatics-Based Selection of Small Molecule Binary Weapons That Improve Transporter-Mediated Targeting: A Cytotoxicity System Based on Gemcitabine |
Q47317732 | FAF-Drugs4: free ADME-tox filtering computations for chemical biology and early stages drug discovery |
Q99589896 | In Vitro Biopredictive Methods: A Workshop Summary Report |
Q92256354 | Ionic Liquid Forms of the Antimalarial Lumefantrine in Combination with LFCS Type IIIB Lipid-Based Formulations Preferentially Increase Lipid Solubility, In Vitro Solubilization Behavior and In Vivo Exposure |
Q51313759 | Lipophilicity in Drug Development: Too Much or Not Enough? |
Q104569806 | Mechanistic Oral Absorption Modeling of Halofantrine: Exploring the Role of Intestinal Lymphatic Transport |
Q39411779 | Review and analysis of FDA approved drugs using lipid-based formulations. |
Q91750784 | Setting Our Sights on Infectious Diseases |
Q51050981 | Systematic Understanding of the Mechanism of Salvianolic Acid A via Computational Target Fishing |
Q64075810 | Systematic elucidation of the mechanism of geraniol via network pharmacology |
Search more.